Sunwin Stevia International Inc. (SUWN)
Stock Price:
$0.0651 USD
-0.0344 (-34.57%)
Updated Aug 10, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
13.00M |
| Revenue (ttm) |
26.09M |
| Net Income (ttm) |
-1.38M |
| Shares Out |
199.63M |
| EPS (ttm) |
-0.01 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 10, 2020 |
| Last Price |
$0.0651 |
| Previous Close |
$0.0995 |
| Change ($) |
-0.0344 |
| Change (%) |
-34.57% |
| Day's Open |
0.0651 |
| Day's Range |
0.0651 - 0.0651 |
| Day's Volume |
450 |
| 52-Week Range |
0.0311 - 0.1600 |
More Stats
| Market Cap |
13.00M |
| Enterprise Value |
15.24M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
199.63M |
| Float |
189.46M |
| EPS (basic) |
-0.01 |
| EPS (diluted) |
-0.01 |
| FCF / Share |
0.00 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
2.99% |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
1.06 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
33.44 |
| PS Ratio |
0.50 |
| PB Ratio |
1.61 |
| Revenue |
26.09M |
| Operating Income |
-443,104 |
| Net Income |
-1.38M |
| Free Cash Flow |
388,648 |
| Net Cash |
-2.24M |
| Net Cash / Share |
-0.01 |
| Gross Margin |
16.86% |
| Operating Margin |
-1.70% |
| Profit Margin |
-5.30% |
| FCF Margin |
1.49% |
| ROA |
-0.85% |
| ROE |
-14.20% |
| ROIC |
-3.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
0.65
Current: $0.0651
High
0.65
Target: 0.65
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Revenue | 26.09 | 20.85 | 19.14 | 19.35 | 18.02 | 17.51 | 12.87 | 9.80 | 12.93 | 9.58 |
| Revenue Growth | 25.14% | 8.92% | -1.1% | 7.44% | 2.87% | 36.03% | 31.33% | -24.2% | 34.95% | - |
| Gross Profit | 4.40 | 1.58 | 1.63 | 2.83 | 1.97 | 3.34 | 2.41 | 2.06 | 1.91 | 1.45 |
| Operating Income | -0.44 | -3.97 | -3.80 | -3.26 | -3.39 | -2.96 | -3.58 | -3.50 | -3.15 | -3.85 |
| Net Income | -1.38 | -4.91 | -4.71 | -3.90 | -4.80 | -4.52 | -3.07 | -4.01 | -4.34 | -4.91 |
| Shares Outstanding | 200 | 200 | 200 | 200 | 182 | 174 | 174 | 168 | 157 | 157 |
| Earnings Per Share | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 |
| Operating Cash Flow | 2.16 | -5.44 | -2.09 | -4.55 | 0.05 | -0.88 | 1.30 | -2.00 | -3.95 | 0.55 |
| Capital Expenditures | -1.77 | -2.36 | -0.78 | -0.70 | -0.40 | -0.36 | -0.85 | -3.27 | -1.63 | -0.49 |
| Free Cash Flow | 0.39 | -7.80 | -2.87 | -5.25 | -0.35 | -1.24 | 0.45 | -5.27 | -5.58 | 0.06 |
| Cash & Equivalents | 1.14 | 0.29 | 0.08 | 0.05 | 0.90 | 0.24 | 1.20 | 0.60 | 5.03 | 11.07 |
| Total Debt | 3.38 | 15.93 | 9.99 | 7.27 | 2.13 | 1.71 | 0.81 | 0.80 | - | - |
| Net Cash / Debt | -2.24 | -15.63 | -9.91 | -7.22 | -1.23 | -1.47 | 0.38 | -0.20 | 5.03 | 11.07 |
| Assets | 29.36 | 35.49 | 33.59 | 27.24 | 27.97 | 26.00 | 28.85 | 30.94 | 31.13 | 33.06 |
| Liabilities | 16.98 | 31.95 | 24.59 | 14.43 | 10.40 | 6.78 | 5.34 | 4.61 | 4.21 | 2.62 |
| Book Value | 12.37 | 3.54 | 9.00 | 12.81 | 17.57 | 19.22 | 23.50 | 26.34 | 26.92 | 28.33 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Sunwin Stevia International Inc. |
| Country |
China |
| CEO |
Dong Dong Lin |
Stock Information
| Ticker Symbol |
SUWN |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
OTCMKTS: SUWN |
Description
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It provides Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.